Brother Technology transfers 15.194% stake in Zhonghua Chemical for 150 million yuan, two lawsuits reach mediation

Corporate ActionRegulation
โดย Jiemian·CN·Read original
Summary · why it matters

Brother Technology Co., Ltd. announced that, under the auspices of the Supreme People's Court, it has reached a package mediation plan with Jiaxing Zhonghua Chemical and Shanghai Xinchen regarding a technology secret infringement case and a share repurchase dispute case, and has received the Civil Mediation Document from the Supreme People's Court. The company transferred its 15.194% stake in Zhonghua Chemical to 10 other individual shareholders of Zhonghua Chemical for a total price of 150 million yuan, and the payment was received on August 25, 2026. At the same time, the company has withdrawn its lawsuit in the share repurchase dispute case, and the court has granted permission; Zhonghua Chemical and Shanghai Xinchen have abandoned all litigation claims in the technology secret infringement case and promised not to assert any rights against the company and Brother Pharmaceutical regarding the technology secrets involved. These two cases lasted for many years. In the technology secret infringement case, the Zhejiang Provincial High People's Court dismissed the plaintiff's claims at first instance, and the plaintiff appealed to the Supreme People's Court. In the share repurchase dispute case, the Nanhu District Court of Jiaxing dismissed the case at first instance, and the company appealed to the Jiaxing Intermediate People's Court. The company stated that this equity transfer is a non-trading equity investment, and the difference after deducting costs and expenses from the transfer proceeds will be recorded in retained earnings, with no impact on the company's profit.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 3

嘉兴中华化工有限责任公司Private± Mixed
Regulationrelevance

Reaches mediation, abandons claims in technology secret infringement case, receives stake transfer.

上海欣晨Private± Mixed
Regulationrelevance

Abandons all litigation claims in technology secret infringement case as part of mediation.

兄弟医药Private± Mixed
Regulationrelevance

Mentioned as protected from future claims regarding technology secrets in mediation.

© 2026 MarketDXNews